On a quarterly basis, overall sales increased by 4% to Rs111.12 billion in the quarter. Overall pharmaceutical sales for the fiscal year ending Jwere Rs453.5 billion, up 9% from the previous fiscal year. Clearly, this creates an opportunity, but the government and business players must put in a lot more effort. Pharmaceutical industry growth:ĭespite the fact that Pakistan’s pharmaceutical and healthcare sectors are quickly expanding and evolving, about half of the population still lacks access to modern medicines. In the previous few years, the sector has made significant investments to modernize it, and currently the bulk of the business follows Good Manufacturing Practices (GMP) in compliance with both domestic and international guidance.Ĭurrently, the business can produce a wide range of products, from simple tablets to advanced Biotech, Oncology, and Value Added Generic chemicals. The national pharmaceutical sector has grown steadily throughout the years, notably in the recent decade. The local Pharma market is roughly evenly split between nationals and multinationals in terms of market share. Pakistan’s pharmaceutical sector supplies over 70% of the country’s completed medicinal needs. Pakistan now has around 759 pharmaceutical manufacturing units, including those run by 25 foreign corporations. There was almost no pharmaceutical business in the country when it gained independence in 1947. Pakistan pharmaceutical industry is a thriving and progressive sector.

Pharmaceutical companies in pakistan